Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Clinician-led improvement in cancer care (CLICC) - testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial - study protocol.

Brown BB, Young J, Smith DP, Kneebone AB, Brooks AJ, Xhilaga M, Dominello A, O'Connell DL, Haines M.

Implement Sci. 2014 May 29;9:64. doi: 10.1186/1748-5908-9-64.

PMID:
24884877
[PubMed - in process]
Free PMC Article
2.

Kallikreins as biomarkers for prostate cancer.

Hong SK.

Biomed Res Int. 2014;2014:526341. doi: 10.1155/2014/526341. Epub 2014 Apr 7.

PMID:
24809052
[PubMed - in process]
Free PMC Article
3.

Can microfocal prostate cancer be regarded as low-risk prostate cancer?

Lee SH, Kim KH, Choi JH, Koo KC, Lee DH, Chung BH.

Prostate Int. 2013;1(4):158-62. doi: 10.12954/PI.13028. Epub 2013 Dec 30.

PMID:
24392440
[PubMed]
Free PMC Article
4.

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer.

Shahab AA, Soebadi DM, Djatisoesanto W, Hardjowijoto S, Soetojo S, Hakim L.

Prostate Int. 2013;1(1):23-30. doi: 10.12954/PI.12003. Epub 2013 Jan 31.

PMID:
24223398
[PubMed]
Free PMC Article
5.

Role of prostate volume in the early detection of prostate cancer in a cohort with slowly increasing prostate specific antigen.

Kim YM, Park S, Kim J, Park S, Lee JH, Ryu DS, Choi SH, Cheon SH.

Yonsei Med J. 2013 Sep;54(5):1202-6. doi: 10.3349/ymj.2013.54.5.1202.

PMID:
23918570
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer.

Altintas DM, Allioli N, Decaussin M, de Bernard S, Ruffion A, Samarut J, Vlaeminck-Guillem V.

PLoS One. 2013 Jun 28;8(6):e66278. doi: 10.1371/journal.pone.0066278. Print 2013.

PMID:
23840433
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis.

Wang L, Zang W, Sang Y, Xie D, Wei L, Ji W, Pan Y, Li Z, Shen J, Shi Y.

PLoS One. 2013 Jun 18;8(6):e65651. Print 2013.

PMID:
23824286
[PubMed - as supplied by publisher]
Free PMC Article
8.

Temporal changes in the clinical approach to diagnosing prostate cancer.

Hilton WM, Padalecki SS, Ankerst DP, Leach RJ, Thompson IM.

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):162-8. doi: 10.1093/jncimonographs/lgs038.

PMID:
23271768
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Carbonic anhydrase I as a new plasma biomarker for prostate cancer.

Takakura M, Yokomizo A, Tanaka Y, Kobayashi M, Jung G, Banno M, Sakuma T, Imada K, Oda Y, Kamita M, Honda K, Yamada T, Naito S, Ono M.

ISRN Oncol. 2012;2012:768190. doi: 10.5402/2012/768190. Epub 2012 Nov 19.

PMID:
23213568
[PubMed]
Free PMC Article
10.

Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea.

Kim D, Choi D, Lim JH, Yoon JH, Jeong IG, You D, Hong JH, Ahn H, Kim CS.

Korean J Urol. 2012 Oct;53(10):680-5. doi: 10.4111/kju.2012.53.10.680. Epub 2012 Oct 19.

PMID:
23136627
[PubMed]
Free PMC Article
11.

The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer.

Nguyen CT, Isariyawongse B, Yu C, Kattan MW.

Front Oncol. 2012 Oct 11;2:138. doi: 10.3389/fonc.2012.00138. eCollection 2012.

PMID:
23087901
[PubMed]
Free PMC Article
12.

Various treatment options for benign prostatic hyperplasia: A current update.

Shrivastava A, Gupta VB.

J Midlife Health. 2012 Jan;3(1):10-9. doi: 10.4103/0976-7800.98811.

PMID:
22923974
[PubMed]
Free PMC Article
13.

Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10‚ÄČng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?

Taverna G, Benecchi L, Grizzi F, Seveso M, Giusti G, Piccinelli A, Benetti A, Colombo P, Minuti F, Graziotti P.

J Oncol. 2012;2012:645146. doi: 10.1155/2012/645146. Epub 2012 Jul 12.

PMID:
22848218
[PubMed]
Free PMC Article
14.

Prostate cancer screening: Attitudes and practices of family physicians in Ontario.

Allard CB, Dason S, Lusis J, Kapoor A.

Can Urol Assoc J. 2012 Jun;6(3):188-93. doi: 10.5489/cuaj.11290.

PMID:
22664631
[PubMed]
Free PMC Article
15.

Formalized prediction of clinically significant prostate cancer: is it possible?

Nguyen CT, Kattan MW.

Asian J Androl. 2012 May;14(3):349-54. doi: 10.1038/aja.2011.140. Epub 2012 Feb 27. Review.

PMID:
22367181
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007.

Dinan MA, Robinson TJ, Zagar TM, Scales CD Jr, Curtis LH, Reed SD, Lee WR, Schulman KA.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e781-6. doi: 10.1016/j.ijrobp.2011.11.024. Epub 2012 Feb 11.

PMID:
22331001
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Smoking and prostate cancer survival and recurrence.

Muller RL, Moreira DM.

Asian J Androl. 2011 Nov;13(6):787-8. doi: 10.1038/aja.2011.126. Epub 2011 Sep 19. No abstract available.

PMID:
21927042
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml.

Kim HW, Ko YH, Kang SH, Lee JG.

Korean J Urol. 2011 Mar;52(3):166-71. doi: 10.4111/kju.2011.52.3.166. Epub 2011 Mar 18.

PMID:
21461279
[PubMed]
Free PMC Article
19.
20.

Novel diagnostic biomarkers for prostate cancer.

Madu CO, Lu Y.

J Cancer. 2010 Oct 6;1:150-77.

PMID:
20975847
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk